350 related articles for article (PubMed ID: 9453429)
1. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy.
Meng LJ; Reyes H; Palma J; Hernandez I; Ribalta J; Sjövall J
J Hepatol; 1997 Dec; 27(6):1029-40. PubMed ID: 9453429
[TBL] [Abstract][Full Text] [Related]
2. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
[TBL] [Abstract][Full Text] [Related]
3. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy.
Meng LJ; Reyes H; Palma J; Hernandez I; Ribalta J; Sjövall J
J Hepatol; 1997 Aug; 27(2):346-57. PubMed ID: 9288610
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
Brites D; Rodrigues CM
J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
[TBL] [Abstract][Full Text] [Related]
5. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy.
Reyes H; Sjövall J
Ann Med; 2000 Mar; 32(2):94-106. PubMed ID: 10766400
[TBL] [Abstract][Full Text] [Related]
6. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine.
Glantz A; Reilly SJ; Benthin L; Lammert F; Mattsson LA; Marschall HU
Hepatology; 2008 Feb; 47(2):544-51. PubMed ID: 17968976
[TBL] [Abstract][Full Text] [Related]
8. Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.
Estiú MC; Monte MJ; Rivas L; Moirón M; Gomez-Rodriguez L; Rodriguez-Bravo T; Marin JJ; Macias RI
Br J Clin Pharmacol; 2015 Feb; 79(2):316-29. PubMed ID: 25099365
[TBL] [Abstract][Full Text] [Related]
9. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
Rodrigues CM; Marín JJ; Brites D
Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
Brites D
Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
[TBL] [Abstract][Full Text] [Related]
11. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
[TBL] [Abstract][Full Text] [Related]
12. The identification of novel steroid N-acetylglucosaminides in the urine of pregnant women.
Meng LJ; Griffiths WJ; Sjövall J
J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):585-98. PubMed ID: 8918986
[TBL] [Abstract][Full Text] [Related]
13. Effect of maternal cholestasis on TGR5 expression in human and rat placenta at term.
Keitel V; Spomer L; Marin JJ; Williamson C; Geenes V; Kubitz R; Häussinger D; Macias RI
Placenta; 2013 Sep; 34(9):810-6. PubMed ID: 23849932
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
Manna LB; Ovadia C; Lövgren-Sandblom A; Chambers J; Begum S; Seed P; Walker I; Chappell LC; Marschall HU; Williamson C
BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939
[TBL] [Abstract][Full Text] [Related]
15. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry.
Almé B; Bremmelgaard A; Sjövall J; Thomassen P
J Lipid Res; 1977 May; 18(3):339-62. PubMed ID: 864325
[TBL] [Abstract][Full Text] [Related]
16. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
Piazza F; Montagnani M; Russo C; Azzaroli F; Aldini R; Roda E; Roda A
Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630
[TBL] [Abstract][Full Text] [Related]
17. Urinary bile acids in late pregnancy and in recurrent cholestasis of pregnancy.
Thomassen PA
Eur J Clin Invest; 1979 Dec; 9(6):425-32. PubMed ID: 119641
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype.
Abu-Hayyeh S; Papacleovoulou G; Lövgren-Sandblom A; Tahir M; Oduwole O; Jamaludin NA; Ravat S; Nikolova V; Chambers J; Selden C; Rees M; Marschall HU; Parker MG; Williamson C
Hepatology; 2013 Feb; 57(2):716-26. PubMed ID: 22961653
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.
Serrano MA; Brites D; Larena MG; Monte MJ; Bravo MP; Oliveira N; Marin JJ
J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319
[TBL] [Abstract][Full Text] [Related]
20. Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid.
Fracchia M; Setchell KD; Crosignani A; Podda M; O'Connell N; Ferraris R; Hofmann AF; Galatola G
Clin Chim Acta; 1996 Apr; 248(2):175-85. PubMed ID: 8740581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
